United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 4, 2026 · Filed Sep 8, 2026

On Sep 4, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$489.20 for US$4.65M under a trading plan, leaving 324,443 shares. Filed Sep 8, 2026 (Form 4).

Sold
9,500 shares
Price
US$489.20 average (US$485.85 to US$491.69)
Value
US$4.65M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 4, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 4, 2026Common StockSale40US$485.85333,903Indirect
Sep 4, 2026Common StockSale223US$486.88333,680Indirect
Sep 4, 2026Common StockSale2,818US$488.08330,862Indirect
Sep 4, 2026Common StockSale3,425US$489.12327,437Indirect
Sep 4, 2026Common StockSale1,514US$490.01325,923Indirect
Sep 4, 2026Common StockSale1,160US$490.94324,763Indirect
Sep 4, 2026Common StockSale320US$491.69324,443Indirect

Source

View original at SEC

Related